Drugs / Rhophylac®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02246842 Comparator | May → Dec 2004 | — | Bio Products Laboratory | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rhophylac | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02246842 ↗ |
| Modality | Protein / enzyme biologic | “human anti-D immunoglobulin” NCT02246842 ↗ |